Therese A. Stukel

Therese A. Stukel

Auto-generated profile, based on publicly available information

Therese A. Stukel

ICES, Toronto, Canada

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2002 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
JBJohn D. Birkmeyer
John D. Birkmeyer
ASAndrea E. Siewers
Andrea E. Siewers
EFEmily V.A. Finlayson
Emily V.A. Finlayson
TSTherese A. Stukel
Therese A. Stukel
FLF. Lee Lucas
F. Lee Lucas
DWDavid E. Wennberg
David E. Wennberg
Although numerous studies suggest that there is an inverse relation between hospital volume of surgical procedures and surgical mortality, the relative importance of hospital volume in various surgical procedures is disputed.

27 November 2003 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
JBJohn D. Birkmeyer
John D. Birkmeyer
TSTherese A. Stukel
Therese A. Stukel
ASAndrea E. Siewers
Andrea E. Siewers
PGPhilip P. Goodney
Philip P. Goodney
DWDavid E. Wennberg
David E. Wennberg
FLF. Lee Lucas
F. Lee Lucas
Although the relation between hospital volume and surgical mortality is well established, for most procedures, the relative importance of the experience of the operating surgeon is uncertain.

18 February 2003 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
EFElliott S. Fisher
Elliott S. Fisher
DWDavid E. Wennberg
David E. Wennberg
TSThrse A. Stukel
Thrse A. Stukel
DGDaniel J. Gottlieb
Daniel J. Gottlieb
FLF. L. Lucas
F. L. Lucas
ÉPÉtoile L. Pinder
Étoile L. Pinder
Background: The health implications of regional differences in Medicare spending are unknown. Objective: To determine whether regions with higher Medicare spending provide better care. Design: Cohort study. Setting: National study of Medicare beneficiaries. Patients: Patients hospitalized between 1993 and 1995 for hip fracture (n = 614 503), colorectal cancer (n = 195 429), or acute myocardial infarction (n = 159 393) and a representative sample (n = 18 190) drawn from the Medicare Current Beneficiary Survey (19921995). Exposure Measurement: End-of-life spending reflects the component of regional variation in Medicare spending that is unrelated to regional differences in illness. Each cohort member's exposure to different levels of spending was therefore defined by the level of end-of-life spending in his or her hospital referral region of residence (n = 306). Outcome Measurements: Content of care (for example, frequency and type of services received), quality of care (for example, use of aspirin after acute myocardial infarction, influenza immunization), and access to care (for example, having a usual source of care). Results: Average baseline health status of cohort members was similar across regions of differing spending levels, but patients in higher-spending regions received approximately 60% more care. The increased utilization was explained by more frequent physician visits, especially in the inpatient setting (rate ratios in the highest vs. the lowest quintile of hospital referral regions were 2.13 [95% CI, 2.12 to 2.14] for inpatient visits and 2.36 [CI, 2.33 to 2.39] for new inpatient consultations), more frequent tests and minor (but not major) procedures, and increased use of specialists and hospitals (rate ratio in the highest vs. the lowest quintile was 1.52 [CI, 1.50 to 1.54] for inpatient days and 1.55 [CI, 1.50 to 1.60] for intensive care unit days). Quality of care in higher-spending regions was no better on most measures and was worse for several preventive care measures. Access to care in higher-spending regions was also no better or worse. Conclusions: Regional differences in Medicare spending are largely explained by the more inpatient-based and specialist-oriented pattern of practice observed in high-spending regions. Neither quality of care nor access to care appear to be better for Medicare enrollees in higher-spending regions.

18 February 2003 in Annals of Internal Medicine
Verified
Journal Article
Open access
PDF file
EFElliott S. Fisher
Elliott S. Fisher
DWDavid E. Wennberg
David E. Wennberg
TSThrse A. Stukel
Thrse A. Stukel
DGDaniel J. Gottlieb
Daniel J. Gottlieb
FLF. L. Lucas
F. L. Lucas
ÉPÉtoile L. Pinder
Étoile L. Pinder
Background: The health implications of regional differences in Medicare spending are unknown. Objective: To determine whether regions with higher Medicare spending achieve better survival, functional status, or satisfaction with care. Design: Cohort study. Setting: National study of Medicare beneficiaries. Patients: Patients hospitalized between 1993 and 1995 for hip fracture (n = 614 503), colorectal cancer (n = 195 429), or acute myocardial infarction (n = 159 393) and a representative sample (n = 18 190) drawn from the Medicare Current Beneficiary Survey (MCBS) (19921995). Exposure Measurement: End-of-life spending reflects the component of regional variation in Medicare spending that is unrelated to regional differences in illness. Each cohort member's exposure to different levels of spending was therefore defined by the level of end-of-life spending in his or her hospital referral region of residence (n = 306). Outcome Measurements: 5-year mortality rate (all four cohorts), change in functional status (MCBS cohort), and satisfaction (MCBS cohort). Results: Cohort members were similar in baseline health status, but those in regions with higher end-of-life spending received 60% more care. Each 10% increase in regional end-of-life spending was associated with the following relative risks for death: hip fracture cohort, 1.003 (95% CI, 0.999 to 1.006); colorectal cancer cohort, 1.012 (CI, 1.004 to 1.019); acute myocardial infarction cohort, 1.007 (CI, 1.001 to 1.014); and MCBS cohort, 1.01 (CI, 0.99 to 1.03). There were no differences in the rate of decline in functional status across spending levels and no consistent differences in satisfaction. Conclusions: Medicare enrollees in higher-spending regions receive more care than those in lower-spending regions but do not have better health outcomes or satisfaction with care. Efforts to reduce spending should proceed with caution, but policies to better manage further spending growth are warranted.

1 June 2011 in BMJ
Verified
Journal Article
Open access
PDF file
AGAstrid Guttmann
Astrid Guttmann
MSMichael J Schull
Michael J Schull
MVMarian J Vermeulen
Marian J Vermeulen
TST. A. Stukel
T. A. Stukel
Objective To determine whether patients who are not admitted to hospital after attending an emergency department during shifts with long waiting times are at risk for adverse events. Design Population based retrospective cohort study using health administrative databases. Setting High volume emergency departments in Ontario, Canada, fiscal years 2003-7. Participants All emergency department patients who were not admitted (seen and discharged; left without being seen). Outcome measures Risk of adverse events (admission to hospital or death within seven days) adjusted for important characteristics of patients, shift, and hospital. Results 13 934 542 patients were seen and discharged and 617 011 left without being seen. The risk of adverse events increased with the mean length of stay of similar patients in the same shift in the emergency department. For mean length of stay ≥6 v <1 hour the adjusted odds ratio (95% confidence interval) was 1.79 (1.24 to 2.59) for death and 1.95 (1.79 to 2.13) for admission in high acuity patients and 1.71 (1.25 to 2.35) for death and 1.66 (1.56 to 1.76) for admission in low acuity patients). Leaving without being seen was not associated with an increase in adverse events at the level of the patient or by annual rates of the hospital. Conclusions Presenting to an emergency department during shifts with longer waiting times, reflected in longer mean length of stay, is associated with a greater risk in the short term of death and admission to hospital in patients who are well enough to leave the department. Patients who leave without being seen are not at higher risk of short term adverse events.

17 January 2007 in JAMA
Verified
Journal Article
Open access
PDF file
TSThérèse A. Stukel
Thérèse A. Stukel
EFElliott S. Fisher
Elliott S. Fisher
DWDavid E. Wennberg
David E. Wennberg
DADavid A. Alter
David A. Alter
DGDaniel J. Gottlieb
Daniel J. Gottlieb
MVMarian J. Vermeulen
Marian J. Vermeulen
In the face of the financial, practical, and ethical challenges inherent in undertaking randomized clinical trials (RCTs), investigators often use observational data to compare the outcomes of different therapies. These comparisons may be biased due to prognostically important baseline differences among patients, often as a result of unobserved treatment selection biases. Unmeasurable clinical and social interactions in the diagnostic-treatment pathway, and physicians' knowledge of unmeasured prognostic variables, may affect treatment decisions and outcomes. Physicians are frequently risk averse in case selection, performing interventions on lower-risk patients despite greater clinical benefit to higher-risk patients.1-3